Behold the future JSX Aura Aero Era 19-seat hybrid-electric aircraft. Rendering courtesy of JSX

Hop-on jet service JSX is soaring into a more eco-friendly future with plans to acquire more than 300 hybrid-electric airplanes.

The Dallas-based air carrier revealed in a release that they'll add up to 332 small hybrid planes in 2028, allowing them to connect to smaller, underserved communities around the country.

"Following the Biden Administration’s call last week for the aviation industry to cut carbon emissions ... JSX expects to take delivery of its first hybrid-electric aircraft in 2028, shepherding the next chapter of regional aviation as the first in its category to adopt this impactful cutting-edge renewable energy technology," JSX says in the release. "While commercial airlines can serve just 480 airports in the United States, JSX’s small community-friendly Part 135 and Part 380 Public Charter operations, combined with the exceptional performance capabilities of these hybrid-electric airplanes, enables service opportunities to thousands of federally funded airports otherwise inaccessible to people who can’t own or charter an entire aircraft."

The new cutting-edge airplanes will come from manufacturers Electra, Aura Aero, and Heart Aerospace and will include:

  • up to 82 Electra eSTOL 9-seat aircraft (32 firm orders and 50 options)
  • up to 150 Aura Aero Era 19-seat planes (50 firm orders and 100 options)
  • up to 100 Heart Aerospace ES-30 30-seat planes (50 firm orders and 50 options)

JSX currently operates about 50 semi-private planes configured with 30 seats, from private terminals in major cities including Dallas (Love Field) and Houston (Hobby Airport), and in "leisure" markets such as Destin, Florida and the Bahamas. The company recently shifted part of its operational focus to small markets (such as Midland-Odessa).

JSX promises a "no crowds, no lines, and no fuss" travel experience, allowing customers to check in and "hop on" just 20 minutes before departure. The carrier recently came under fire from federal regulators and major commercial airlines for its looser security regulations that more closely resemble those of charter providers than those of domestic airlines.

JSX is now doubling down on its pledge to service underserved cities, declaring in the release, "JSX has mastered the trifecta of marketing, selling, and operating attainable by-the-seat public charter air service to numerous small communities that have no other regular air service."


The future Heart Aerospace ES-30 30-seat hybrid-electric aircraft in JSX livery. Rendering courtesy of JSX


The new smaller, electric-hybrid aircraft will allow JSX to "dramatically lower the cost of its service and open new flight options at over 2,000 U.S. airports," they say, "stimulating local economies and empowering regional mobility and connectivity for communities devoid of regular air service today."

They point specifically to Del Rio, Texas, which has lost all commercial air service since the pandemic, they say, as an example of a small city that now can be reconnected to major cities in a cost-effective, sustainable way.

"The favorable operating economics of the Aura Aero Era, Heart ES-30, and Electra eSTOL can create thousands of new and expanded air travel options across the United States without the need for government subsidy," the company says.

In a statement, JSX CEO and cofounder Alex Wilcox adds, "As the network airlines order ever-larger aircraft it is inevitable that more and more small markets will be abandoned. Electra, Aura Aero, and Heart Aerospace are visionary organizations that share in JSX’s commitment to serving smaller communities, working together with us to weave sustainable regional air travel back into the fabric of American commerce and freedom of movement.”

———

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.